Charles River Laboratorie (CRL) Tops Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $186.60 +2.78%
EPS Growth %: -12.5%
Financial Fact:
Continuing operations (in dollars per share): 0.78
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -12.5%
Financial Fact:
Continuing operations (in dollars per share): 0.78
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Charles River Laboratorie (NYSE: CRL) reported Q4 EPS of $0.81, $0.09 better than the analyst estimate of $0.72. Revenue for the quarter came in at $329.5 million versus the consensus estimate of $318.73 million.
Charles River Laboratorie sees FY2015 EPS of $3.55-$3.65, versus the consensus of $3.58.
For earnings history and earnings-related data on Charles River Laboratorie (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- AeroVironment restates quarterly financials, citing $89M goodwill error
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
